Yes, many patients transition from oral to injectable formulations
Posterior Probability of Equivalence To quantify cross-drug dose comparability, posterior probabilities of clinical equivalence were estimated for prespecified semaglutide doses (1.0, 2.4, 7.2 mg/week) and tirzepatide doses (5, 10, 15 mg/week)
It is amazing at repairing tissue
| Take home message A study presented at the European Congress on Obesity showed that semaglutide (Ozempic/Wegovy) could reduce the number of major cardiovascular events (MACE), like a heart attack or stroke, by 20% compared to placebo (participants not taking the medication)
While the CXXC5 mechanism appears conserved between mice and humans (elevated CXXC5 is found in human bald scalps), the functional response to PTD-DBM treatment in humans may differ in magnitude, timeline, or both
They have FDA approval